Tinaz M.

Tinaz M. brings extensive experience in the pharmaceutical and biotechnology industries, with a focus on oncology and immunology marketing. At Sandoz, Tinaz led the pre and post-launch marketing strategy for Denosumab, achieving significant market share and exceeding year-one revenue targets. Tinaz also served as the Interim Brand Lead for Tyruko, the first FDA-approved biosimilar for multiple sclerosis. Previous roles include positions at Pfizer, where Tinaz transformed sales teams and received multiple awards for excellence, and at Amgen, where market access initiatives for oncology products resulted in over $20 million in contract negotiations. Tinaz possesses a history of driving significant growth through strategic marketing and sales leadership.